Health
Anivive’s GC376 Reduces COVID-19 Replication, Shows Potential as New Post-Infection Treatment – PRNewswire
/PRNewswire/ — The Proceedings of the National Academy of Sciences, one of the world’s most cited and comprehensive scientific…
The PNAS article, “Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection,” details a study that shows mice with fatal SARS-CoV-2 infections experienced reduced viral load and improved survival when…
Continue Reading
-
General22 hours agoMourners arrive for Diogo Jota’s wake in Liverpool forward’s hometown in Portugal
-
Business22 hours ago3 ASX growth shares to buy before the next bull market
-
General8 hours agoMatildas vs Panama international friendly — live blog and scores from Bunbury
-
General21 hours agoDear God! It’s 2028 | The Spectator Australia